In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 01 2020
accepted: 05 11 2020
revised: 23 12 2020
pubmed: 12 12 2020
medline: 3 2 2021
entrez: 11 12 2020
Statut: epublish

Résumé

The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase and critical regulator of cell cycle progression. Despite its vital role, it has remained challenging to globally map APC/C substrates. By combining orthogonal features of known substrates, we predicted APC/C substrates in silico. This analysis identified many known substrates and suggested numerous candidates. Unexpectedly, chromatin regulatory proteins are enriched among putative substrates, and we show experimentally that several chromatin proteins bind APC/C, oscillate during the cell cycle, and are degraded following APC/C activation, consistent with being direct APC/C substrates. Additional analysis revealed detailed mechanisms of ubiquitylation for UHRF1, a key chromatin regulator involved in histone ubiquitylation and DNA methylation maintenance. Disrupting UHRF1 degradation at mitotic exit accelerates G1-phase cell cycle progression and perturbs global DNA methylation patterning in the genome. We conclude that APC/C coordinates crosstalk between cell cycle and chromatin regulatory proteins. This has potential consequences in normal cell physiology, where the chromatin environment changes depending on proliferative state, as well as in disease.

Identifiants

pubmed: 33306668
doi: 10.1371/journal.pbio.3000975
pii: PBIOLOGY-D-20-00069
pmc: PMC7758050
doi:

Substances chimiques

CCAAT-Enhancer-Binding Proteins 0
Cell Cycle Proteins 0
Chromatin 0
Transcription Factors 0
Anaphase-Promoting Complex-Cyclosome EC 2.3.2.27
UHRF1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3000975

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007040
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120309
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA071341
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM128855
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM124736
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM134231
Pays : United States

Déclaration de conflit d'intérêts

I have read the journal's policy and the authors of this manuscript have the following competing interests: NGB is a consultant for Cullgen, Inc.

Références

Methods Mol Biol. 2009;545:301-12
pubmed: 19475397
Cell. 2007 Jul 13;130(1):127-39
pubmed: 17632060
Nat Struct Mol Biol. 2012 Nov;19(11):1155-60
pubmed: 23022729
Science. 2007 Sep 21;317(5845):1760-4
pubmed: 17673620
Nature. 1999 Oct 21;401(6755):815-8
pubmed: 10548110
Nat Cell Biol. 2009 Nov;11(11):1363-9
pubmed: 19820702
Stem Cells. 2018 Nov;36(11):1736-1751
pubmed: 29999568
Epigenetics. 2009 Jan;4(1):8-14
pubmed: 19077538
Cell Cycle. 2007 Oct 15;6(20):2516-23
pubmed: 17726374
Mol Cell. 2015 Sep 3;59(5):867-81
pubmed: 26051181
Cancer Cell. 2019 Apr 15;35(4):633-648.e7
pubmed: 30956060
Nature. 2007 Dec 6;450(7171):908-12
pubmed: 17994007
J Cell Biol. 2010 Jun 14;189(6):981-96
pubmed: 20548101
Nature. 2017 Sep 13;549(7671):219-226
pubmed: 28905911
Sci Signal. 2010 Jan 12;3(104):ra3
pubmed: 20068231
Cancer Discov. 2017 Apr;7(4):424-441
pubmed: 28174173
Epigenomics. 2009 Oct;1(1):177-200
pubmed: 22122642
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nature. 2014 Sep 18;513(7518):388-393
pubmed: 25043029
Cancer Cell. 2010 Oct 19;18(4):382-95
pubmed: 20951947
Cancer Res. 2011 May 15;71(10):3447-52
pubmed: 21270108
Genes (Basel). 2018 Dec 03;9(12):
pubmed: 30513966
Nature. 1996 Jul 25;382(6589):319-24
pubmed: 8684459
Biochemistry. 1993 Sep 21;32(37):9859-65
pubmed: 8373784
Methods Enzymol. 2005;399:21-36
pubmed: 16338346
Nat Commun. 2015 Jan 06;6:5906
pubmed: 25562820
Cancer Cell. 2014 Feb 10;25(2):196-209
pubmed: 24486181
Mol Cell Biol. 2008 Sep;28(17):5162-71
pubmed: 18573889
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2543-8
pubmed: 19181856
Nat Rev Mol Cell Biol. 2015 Feb;16(2):82-94
pubmed: 25604195
Nucleic Acids Res. 2018 Nov 16;46(20):e123
pubmed: 30085201
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Cell Sci. 2010 Feb 1;123(Pt 3):321-30
pubmed: 20053638
Biochim Biophys Acta Mol Cell Res. 2018 Dec;1865(12):1924-1933
pubmed: 30290241
EMBO J. 2014 Dec 1;33(23):2860-79
pubmed: 25349192
Genes Dev. 2013 Jun 1;27(11):1288-98
pubmed: 23752590
Elife. 2016 Sep 06;5:
pubmed: 27595565
Mol Biol Cell. 2013 Oct;24(19):3025-37
pubmed: 23924899
Cell. 2015 Jul 16;162(2):425-440
pubmed: 26186194
Mol Biol Cell. 2013 Dec;24(23):3634-50
pubmed: 24109597
PLoS Biol. 2019 Sep 3;17(9):e3000378
pubmed: 31479438
Genes Dev. 2002 Feb 15;16(4):503-17
pubmed: 11850412
Am J Hum Genet. 2019 Sep 5;105(3):625-630
pubmed: 31303264
Nat Cell Biol. 2008 Jul;10(7):802-11
pubmed: 18552834
Cell Discov. 2017 Jun 13;3:17019
pubmed: 28626588
Nature. 2006 Apr 13;440(7086):954-8
pubmed: 16612388
Mol Cell. 2011 Oct 21;44(2):325-40
pubmed: 21906983
BMC Med Genomics. 2011 Jan 09;4:3
pubmed: 21214954
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2570-8
pubmed: 27114510
Nature. 2013 Oct 10;502(7470):249-53
pubmed: 24013172
Cell. 2005 Sep 23;122(6):915-26
pubmed: 16153703
Mol Cell Proteomics. 2011 Oct;10(10):M111.013284
pubmed: 21890473
Cell Rep. 2013 Apr 25;3(4):1105-16
pubmed: 23545495
Nature. 2009 Nov 19;462(7271):315-22
pubmed: 19829295
Cell Rep. 2017 Sep 26;20(13):3212-3222
pubmed: 28954236
Nucleic Acids Res. 2013 Mar 1;41(5):2846-56
pubmed: 23325852
Cell Cycle. 2013 Sep 15;12(18):2992-3000
pubmed: 23974109
Cell Rep. 2015 Mar 31;10(12):1957-66
pubmed: 25818288
Genome Biol. 2004;5(10):R80
pubmed: 15461798
Genomics. 2011 Oct;98(4):288-95
pubmed: 21839163
Cell. 2000 Aug 18;102(4):411-24
pubmed: 10966104
Mol Biol Cell. 2011 Jul 1;22(13):2175-84
pubmed: 21562221
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Mol Cell Proteomics. 2014 Sep;13(9):2411-25
pubmed: 24857844
Nat Struct Mol Biol. 2013 Jul;20(7):827-35
pubmed: 23708605
Mol Biol Cell. 2002 Jun;13(6):1977-2000
pubmed: 12058064
EMBO J. 2001 Feb 15;20(4):792-801
pubmed: 11179223
EMBO J. 2018 Aug 15;37(16):
pubmed: 29973362
Open Biol. 2017 Nov;7(11):
pubmed: 29167309
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5272-9
pubmed: 25825779
Mol Cell. 2016 Oct 6;64(1):12-23
pubmed: 27716480
Nucleus. 2015;6(2):123-32
pubmed: 25891992
Cell. 2016 Jun 30;166(1):167-80
pubmed: 27368103
Nat Commun. 2016 Jan 05;7:10201
pubmed: 26727879
Mol Cell. 2013 Jun 6;50(5):649-60
pubmed: 23707760
Nat Commun. 2018 Nov 14;9(1):4776
pubmed: 30429481
Cell Syst. 2016 Oct 26;3(4):395-403.e4
pubmed: 27667366
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18213-8
pubmed: 19822757
J Neurochem. 2019 Oct;151(1):103-115
pubmed: 31318984
F1000Res. 2016 Jun 08;5:1281
pubmed: 27347385
Annu Rev Cell Dev Biol. 2018 Oct 6;34:137-162
pubmed: 30110556
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Genome Res. 2011 Nov;21(11):1833-40
pubmed: 21957152
Methods Enzymol. 2005;399:404-14
pubmed: 16338372
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):955-60
pubmed: 18195366
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7
pubmed: 18669648
Cancer Discov. 2017 Feb;7(2):218-233
pubmed: 28069571
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13415-20
pubmed: 18757745
Mol Biol Cell. 2020 Apr 1;31(8):725-740
pubmed: 31995441
Oncotarget. 2017 Apr 24;8(31):51946-51962
pubmed: 28881702
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cell. 2013 Feb 28;152(5):1160-72
pubmed: 23452859
Cell. 2011 Oct 14;147(2):459-74
pubmed: 21963094
Cell. 2014 May 8;157(4):910-21
pubmed: 24813613
Front Genet. 2015 Feb 03;6:19
pubmed: 25691891
EMBO J. 2014 Feb 18;33(4):385-99
pubmed: 24510915
Cell. 2016 Jun 2;165(6):1440-1453
pubmed: 27259151
Cell Res. 2015 Aug;25(8):911-29
pubmed: 26065575

Auteurs

Jennifer L Franks (JL)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Raquel C Martinez-Chacin (RC)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Xianxi Wang (X)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Rochelle L Tiedemann (RL)

Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.

Thomas Bonacci (T)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Rajarshi Choudhury (R)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Derek L Bolhuis (DL)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Taylor P Enrico (TP)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Ryan D Mouery (RD)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Jeffrey S Damrauer (JS)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Feng Yan (F)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Joseph S Harrison (JS)

Department of Chemistry, University of the Pacific, Stockton, California, United States of America.

M Ben Major (MB)

Department of Cell Biology and Physiology, Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri, United States of America.

Katherine A Hoadley (KA)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Aussie Suzuki (A)

McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America.

Scott B Rothbart (SB)

Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.

Nicholas G Brown (NG)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Michael J Emanuele (MJ)

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH